We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

157 hedge funds and large institutions have $2.16B invested in Relay Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

18% more call options, than puts

Call options by funds: $5.12M | Put options by funds: $4.35M

14% more capital invested

Capital invested by funds: $1.9B → $2.16B (+$258M)

2% more ownership

Funds ownership: 105.95% → 107.95% (+2%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

5% less funds holding

Funds holding: 165 → 157 (-8)

22% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 32

Holders
157
Holders Change
-8
Holders Change %
-4.85%
% of All Funds
2.5%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
25
Increased
50
Reduced
50
Closed
32
Calls
$5.12M
Puts
$4.35M
Net Calls
+$769K
Net Calls Change
-$925K

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$47.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$42.5M
3
MB
MPM BioImpact
Massachusetts
+$22M
4
GPP
Great Point Partners
Connecticut
+$11.8M
5
BBA
Baker Bros. Advisors
New York
+$5.09M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$32.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.6M
3
BI
BVF Inc
California
-$13.5M
4
Millennium Management
Millennium Management
New York
-$10.3M
5
State Street
State Street
Massachusetts
-$6.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
51
Sio Capital Management
New York
$3.79M +$4.12M +230,013 New
TD Asset Management
52
TD Asset Management
Ontario, Canada
$3.57M +$1.67M +93,255 +75%
Barclays
53
Barclays
United Kingdom
$3.2M -$1.39M -77,369 -28%
FIM
54
Fernwood Investment Management
Massachusetts
$3.05M – – –
RPAM
55
Rhenman & Partners Asset Management
Sweden
$3.02M -$179K -10,000 -5%
UBS Group
56
UBS Group
Switzerland
$2.81M -$1.66M -92,437 -35%
Swiss National Bank
57
Swiss National Bank
Switzerland
$2.79M -$341K -19,000 -10%
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.77M +$1.11M +61,822 +58%
Deutsche Bank
59
Deutsche Bank
Germany
$2.59M -$1.43M -79,621 -34%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$2.23M +$120K +6,696 +5%
State of New Jersey Common Pension Fund D
61
State of New Jersey Common Pension Fund D
New Jersey
$2.16M +$119K +6,662 +5%
HS
62
HighVista Strategies
Massachusetts
$2.13M -$848K -47,276 -27%
JFG
63
Jefferies Financial Group
New York
$2.1M +$2.28M +127,300 New
OM
64
Opaleye Management
Massachusetts
$2.07M +$2.25M +125,500 New
Renaissance Technologies
65
Renaissance Technologies
New York
$1.96M +$1.04M +58,054 +95%
IAIM
66
Industrial Alliance Investment Management
Quebec, Canada
$1.82M +$1.98M +110,590 New
Ameriprise
67
Ameriprise
Minnesota
$1.72M +$357K +19,920 +24%
GGHC
68
Gilder Gagnon Howe & Co
New York
$1.69M -$96.1K -5,358 -5%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$1.68M – – –
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$1.66M -$22.8K -1,272 -1%
TC
71
TwinBeech Capital
New York
$1.62M -$1.9M -105,800 -52%
IC
72
Iconiq Capital
California
$1.56M – – –
Wells Fargo
73
Wells Fargo
California
$1.48M +$1.59M +88,819 +9,803%
PA
74
Profund Advisors
Maryland
$1.36M +$1.48M +82,311 New
CS
75
Credit Suisse
Switzerland
$1.34M +$95.9K +5,346 +7%
1 2
3
4 5

RLAY Hedge Fund Activity: Q1 2023 in Review

157 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q1 2023, worth a combined $2.16B — up 14% from $1.9B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of RLAY and 25 opened new positions — a net loss of 7 holders — while 50 trimmed existing stakes and 50 added.

The largest buyer was Casdin Capital, adding an estimated $47.8M. The largest seller was Morgan Stanley, cutting an estimated $32.4M.

  • 157 institutional investors held Relay Therapeutics (RLAY) as of Q1 2023, down from 165 in Q4 2022.
  • Funds reported $2.16B of Relay Therapeutics stock for Q1 2023, up 14% quarter-over-quarter.
  • 25 funds opened new Relay Therapeutics positions in Q1 2023 and 32 closed out, a net change of -7 holders.
  • The largest Relay Therapeutics buyer in Q1 2023 was Casdin Capital, an estimated $47.8M added.
  • The largest Relay Therapeutics seller in Q1 2023 was Morgan Stanley, an estimated $32.4M sold.

Based on aggregated 13F filings for Q1 2023.